Last viewed:
MNK
Prices are updated after-hours
MNK
|
$0.3402
-0.06%
540K
|
n/a
(0.0% 1d)
(1.8% 1m)
(-93.2% 1y)
(0.0% 2d)
(-16.6% 3d)
(0.0% 7d)
(-100.0%
volume)
Earnings Calendar:
Market Cap: $ 4,520,979
http://mallinckrodt.com
Sec
Filling
|
Patents
| 3400 employees
(IE) Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.
brands
add to watch list
Paper trade
email alert is off
Press-releases
Inhaled Nitric Oxide Market to Reach $1.6 billion, Globally, by 2032 at 7.7% CAGR: Allied Market Research
Published: 2024-04-23
(Crawled : 05:00)
- prnewswire.com
LIN
|
News
|
$446.17
-0.18%
320K
|
Process Industries
| 0.0%
| O: 0.45%
H: 0.0%
C: 0.0%
reach
research
market
Mallinckrodt Announces 2024 Extracorporeal Immunomodulation Award
Published: 2024-04-14
(Crawled : 20:20)
- prnewswire.com
MNKKQ
|
$0.02
|
Manufacturing
| Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
| Email alert
Add to watchlist
MNKPF
|
$17.25
|
n/a
| Email alert
Add to watchlist
MNKTQ
|
$0.12
-66.67%
39K
|
Manufacturing
| Email alert
Add to watchlist
award
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Published: 2024-04-12
(Crawled : 14:30)
- prnewswire.com
HAE
|
$85.27
1.97%
39K
|
Health Technology
| -3.35%
| O: -0.62%
H: 0.28%
C: -0.88%
BDX
|
$234.72
0.36%
150K
|
Health Technology
| -2.8%
| O: -0.62%
H: 0.37%
C: -1.66%
BAX
|
$40.965
1.4%
810K
|
Health Technology
| -4.08%
| O: -0.9%
H: 0.38%
C: -3.38%
CTSO
|
$0.815
0.62%
27K
|
Health Technology
| -10.48%
| O: -1.64%
H: 7.87%
C: -2.02%
CERS
|
$1.755
3.85%
440K
|
Health Technology
| -0.29%
| O: 3.24%
H: 12.0%
C: 0.0%
market
Apheresis Devices Market size is set to grow by USD 1.59 bn from 2024-2028,growth in new indications for plasma products boost the market- Technavio
Published: 2024-04-08
(Crawled : 22:00)
- prnewswire.com
TRUMF
|
$16.488
1.7K
|
Health Technology
| -2.37%
| O: 1.46%
H: 3.63%
C: 3.63%
TRUMY
|
$16.94
52K
|
Manufacturing
| -51.97%
| O: -51.77%
H: 3.0%
C: 2.06%
for
set
market
Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 Guidance
Published: 2024-03-26
(Crawled : 20:00)
- prnewswire.com
MNKKQ
|
$0.02
|
Manufacturing
| Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
| Email alert
Add to watchlist
MNKPF
|
$17.25
|
n/a
| Email alert
Add to watchlist
MNKTQ
|
$0.12
-66.67%
39K
|
Manufacturing
| Email alert
Add to watchlist
year
financial
results
Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients
Published: 2024-03-11
(Crawled : 12:00)
- biospace.com/
MNKKQ
|
$0.02
|
Manufacturing
| Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
| Email alert
Add to watchlist
MNKPF
|
$17.25
|
n/a
| Email alert
Add to watchlist
MNKTQ
|
$0.12
-66.67%
39K
|
Manufacturing
| Email alert
Add to watchlist
acthar
publication
treat
gel
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published: 2024-03-07
(Crawled : 12:00)
- prnewswire.com
PFE
|
News
A
|
$26.34
0.31%
7.7M
|
Health Technology
| -3.42%
| O: 0.04%
H: 0.44%
C: -1.51%
NVS
|
News
|
$97.63
2.64%
1.6M
|
Health Technology
| -7.67%
| O: -2.08%
H: 0.13%
C: -0.57%
BMY
|
$49.2
0.12%
2.9M
|
Health Technology
| -7.94%
| O: 0.36%
H: 0.34%
C: -0.54%
XFOR
|
$1.335
-1.84%
1.2M
|
Health Technology
| 41.15%
| O: 0.12%
H: 0.0%
C: -4.98%
EYPT
|
News
|
$18.025
6.34%
370K
|
Health Technology
| -34.15%
| O: 2.56%
H: 1.37%
C: -4.13%
AQST
|
$4.345
-0.8%
800K
|
Health Technology
| -12.92%
| O: 1.79%
H: 12.3%
C: 10.94%
ALKS
|
$24.58
2.12%
300K
|
Health Technology
| -16.83%
| O: 1.11%
H: 0.96%
C: 0.65%
Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector
Published: 2024-03-01
(Crawled : 15:00)
- biospace.com/
MNKKQ
|
$0.02
|
Manufacturing
| Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
| Email alert
Add to watchlist
MNKPF
|
$17.25
|
n/a
| Email alert
Add to watchlist
MNKTQ
|
$0.12
-66.67%
39K
|
Manufacturing
| Email alert
Add to watchlist
acthar
fda
drug
approval
gel
application
The Radiopharmaceuticals Market to grow by USD 4.61 billion from 2022 to 2027, North America is estimated to contribute 42% to the growth - Technavio
Published: 2024-02-06
(Crawled : 09:00)
- prnewswire.com
NVSEF
|
News
|
$95.11
490
|
Health Technology
| -8.33%
| O: 0.72%
H: 0.0%
C: -1.56%
NVS
|
News
|
$97.63
2.64%
1.6M
|
Health Technology
| -8.41%
| O: -0.15%
H: 0.6%
C: 0.42%
america
growth
market
Mallinckrodt Announces Board of Directors and Leadership Updates
Published: 2024-02-02
(Crawled : 15:00)
- biospace.com/
MS
|
News
0
d
|
$93.2
1.21%
1.1M
|
Finance
| 6.07%
| O: -0.4%
H: 1.39%
C: 0.93%
LLY
|
News
|
$742.04
1.46%
540K
|
Health Technology
| 10.74%
| O: 0.3%
H: 1.55%
C: 0.8%
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount